Zakrzepica żył głębokich
Zapobieganie i profilaktyka

Zakrzepica żył głębokich (ZŻG) stanowi istotne zagrożenie u pacjentów hospitalizowanych, szczególnie po zabiegach chirurgicznych i u osób z licznymi czynnikami ryzyka, takimi jak unieruchomienie, wiek zaawansowany, otyłość czy choroby współistniejące. Profilaktyka ZŻG, obejmująca ocenę ryzyka oraz zastosowanie farmakologicznych i mechanicznych metod zapobiegania, może zmniejszyć ryzyko wystąpienia zakrzepicy o 10-80%. Farmakologicznie preferowane są heparyny drobnocząsteczkowe (LMWH), heparyna niefrakcjonowana (UFH) oraz fondaparinux, a u pacjentów po dużych zabiegach ortopedycznych także doustne antykoagulanty bezpośrednie (DOAC). Zalecane jest rozpoczęcie profilaktyki farmakologicznej w ciągu 12 godzin po operacji, a jej czas trwania wynosi zwykle 10-14 dni, z możliwością wydłużenia do 28-35 dni w przypadku wysokiego ryzyka. Metody mechaniczne, takie jak pończochy uciskowe (15-30 mmHg), przerywana kompresja pneumatyczna (IPC) oraz pompy stóp żylnych, są stosowane u pacjentów z przeciwwskazaniami do antykoagulantów lub zwiększonym ryzykiem krwawienia, poprawiając przepływ krwi i zmniejszając zastój żylnego.

Profilaktyka zakrzepicy żył głębokich

Zakrzepica żył głębokich (ZŻG) to stan, w którym dochodzi do powstania zakrzepu w głębokich żyłach, najczęściej kończyn dolnych. Profilaktyka ZŻG jest niezwykle istotna, ponieważ pozwala zmniejszyć ryzyko wystąpienia zatorowości płucnej, która jest poważnym, zagrażającym życiu powikłaniem. Wdrożenie odpowiednich działań profilaktycznych może zmniejszyć ryzyko wystąpienia ZŻG o 10-80%, w zależności od zastosowanych metod i czynników ryzyka pacjenta12.

Ocena ryzyka ZŻG

Pierwszym krokiem w profilaktyce ZŻG jest ocena ryzyka jej wystąpienia. Pacjenci hospitalizowani mają zwiększone ryzyko zakrzepicy żył głębokich w porównaniu do osób z populacji ogólnej3. Na podstawie czynników ryzyka, pacjentów klasyfikuje się do grup niskiego, umiarkowanego i wysokiego ryzyka4. Ocena ryzyka powinna być przeprowadzona u każdego pacjenta przyjmowanego do szpitala i powtórzona w ciągu 24 godzin lub gdy nastąpi zmiana stanu klinicznego5.

Do czynników zwiększających ryzyko ZŻG należą: zabieg chirurgiczny, unieruchomienie, zaawansowany wiek, otyłość, ciąża, stosowanie leków hormonalnych, nowotwór złośliwy, przebyte epizody ZŻG, zaburzenia krzepnięcia, niewydolność serca, choroby zapalne jelit, choroby nerek oraz palenie tytoniu6.

Metody profilaktyki ZŻG

Profilaktyka ZŻG może być pierwotna lub wtórna. Profilaktyka pierwotna, która jest preferowanym podejściem, obejmuje stosowanie leków i metod mechanicznych w celu zapobiegania ZŻG78. Profilaktyka ZŻG działa poprzez wpływ na zastój krwi (metody mechaniczne) lub nadkrzepliwość (profilaktyka farmakologiczna)9.

Profilaktyka farmakologiczna

Powszechnie stosowanymi lekami w profilaktyce ZŻG u pacjentów hospitalizowanych są10:

  • Heparyny drobnocząsteczkowe (LMWH, np. Lovenox)
  • Heparyna niefrakcjonowana (UFH)
  • Fondaparinux
  • Doustne antykoagulanty bezpośrednie (DOAC)

11

American Society of Hematology (ASH) w wytycznych z 2018 roku dotyczących profilaktyki ZŻG zdecydowanie zaleca profilaktykę farmakologiczną z zastosowaniem heparyny niefrakcjonowanej, heparyny drobnocząsteczkowej lub fondaparinuxu u pacjentów hospitalizowanych z chorobami ostrymi i krytycznymi, o ile nie ma przeciwwskazań12.

W przypadku pacjentów poddawanych dużym zabiegom ortopedycznym, takim jak całkowita wymiana stawu biodrowego czy kolanowego, zaleca się stosowanie wybranych doustnych antykoagulantów, LMWH, fondaparinuxu lub warfaryny w dostosowanej dawce13.

Rozpoczęcie profilaktyki farmakologicznej powinno nastąpić w ciągu 12 godzin po zakończeniu operacji u pacjentów chirurgicznych14. W przypadku pacjentów z wysokim ryzykiem ZŻG po zabiegu ortopedycznym, profilaktyka powinna być kontynuowana przez co najmniej 10-14 dni, a w niektórych przypadkach przez 28-35 dni1516.

Metody mechaniczne

Metody mechaniczne są stosowane u pacjentów z umiarkowanym do wysokiego ryzykiem ZŻG, u których występuje zwiększone ryzyko krwawienia17. Obejmują one18:

  • Pończochy uciskowe (stopniowane) – zakładane na nogi pończochy zapewniające ucisk 15-30 mmHg
  • Urządzenia do przerywanego ucisku pneumatycznego (IPC) – rękaw zakładany na kończynę dolną, który okresowo pompuje powietrze, stymulując przepływ krwi
  • Pompy stóp żylnych (VFP) – urządzenia stymulujące przepływ krwi poprzez ucisk stóp

1920

Mechaniczne metody profilaktyki mają na celu zmniejszenie zastoju żylnego, poprawę prędkości przepływu krwi i zwiększenie poziomu krążących fibrynolizyn21. Nie zwiększają one ryzyka krwawienia i są generalnie dobrze tolerowane22.

Profilaktyka u pacjentów hospitalizowanych

U pacjentów hospitalizowanych z chorobami ostrymi lub po zabiegach chirurgicznych zaleca się23:

  • Wczesną mobilizację – wstawanie z łóżka i ruch jak najszybciej po zabiegu
  • Stosowanie farmakologicznej profilaktyki przeciwzakrzepowej
  • Używanie urządzeń do kompresji mechanicznej
  • Noszenie pończoch kompresyjnych
  • Wykonywanie ćwiczeń mięśni łydek i stóp

2425

Przy wypisie ze szpitala, u pacjentów z wysokim ryzykiem ZŻG, może być konieczne kontynuowanie profilaktyki przeciwzakrzepowej w domu, w tym stosowanie leków przeciwkrzepliwych i noszenie pończoch uciskowych2627.

Profilaktyka podczas podróży

Długotrwałe podróże (powyżej 4-6 godzin) mogą zwiększać ryzyko ZŻG, choć jest ono stosunkowo niewielkie2829. W celu zmniejszenia ryzyka ZŻG podczas długich podróży zaleca się3031:

  • Regularne wstawanie i chodzenie (co najmniej raz na godzinę)
  • Wykonywanie ćwiczeń mięśni łydek i stóp podczas siedzenia
  • Unikanie krzyżowania nóg
  • Wybieranie miejsc przy przejściu, które umożliwiają łatwiejsze wstawanie
  • Noszenie luźnych ubrań
  • Utrzymywanie nawodnienia (unikanie alkoholu i kofeiny)
  • Noszenie pończoch uciskowych (15-30 mmHg) u osób ze zwiększonym ryzykiem ZŻG

3233

W przypadku podróżnych długodystansowych (powyżej 6 godzin) ze zwiększonym ryzykiem ZŻG, American College of Chest Physicians zaleca częste chodzenie, ćwiczenia mięśni łydek, siedzenie przy przejściu oraz stosowanie odpowiednio dopasowanych pończoch uciskowych poniżej kolana34.

Profilaktyka u pacjentów onkologicznych

Pacjenci z chorobą nowotworową mają zwiększone ryzyko ZŻG. Wytyczne opublikowane przez National Comprehensive Cancer Network (NCCN), American Society of Clinical Oncology (ASCO) i międzynarodową grupę konsensusową nie zalecają rutynowej profilaktyki ZŻG u ambulatoryjnych pacjentów z chorobą nowotworową, z wyjątkiem osób z bardzo wysokim ryzykiem ZŻG35.

W wybranych sytuacjach, takich jak u osób poddawanych leczeniu z powodu nowotworu, które są obarczone wysokim ryzykiem ZŻG (np. pacjenci z rakiem żołądka lub trzustki otrzymujący chemioterapię), można rozważyć stosowanie antykoagulantów w celu zapobiegania ZŻG36.

Profilaktyka ZŻG po zabiegach ortopedycznych

Duże zabiegi ortopedyczne, takie jak całkowita wymiana stawu biodrowego, całkowita wymiana stawu kolanowego lub operacja złamania biodra, wiążą się z wysokim ryzykiem ZŻG. Jeśli nie stosuje się profilaktyki po tych zabiegach, objawowa ZŻG ma około 4% szansy rozwoju w ciągu 35 dni37.

Po dużych zabiegach ortopedycznych zaleca się połączenie leku przeciwkrzepliwego lub aspiryny z przerywanym uciskiem pneumatycznym, który jest preferowaną metodą mechanicznej profilaktyki w porównaniu do pończoch uciskowych38.

Amerykańska Akademia Chirurgów Ortopedycznych (AAOS) zaleca3940:

  • Wczesne uruchamianie i ćwiczenia
  • Stosowanie pończoch uciskowych
  • Stosowanie leków przeciwkrzepliwych

Profilaktyka powinna być kontynuowana przez co najmniej 10-14 dni po zabiegu, a w przypadkach wysokiego ryzyka przez 28-35 dni4142.

Zmiany stylu życia w profilaktyce ZŻG

Zmiany stylu życia mogą pomóc w zapobieganiu ZŻG. Zalecane działania obejmują4344:

  • Regularna aktywność fizyczna – co najmniej 30 minut umiarkowanej aktywności fizycznej dziennie
  • Utrzymywanie prawidłowej masy ciała
  • Unikanie palenia tytoniu
  • Odpowiednie nawodnienie
  • Unikanie długotrwałego unieruchomienia
  • Unikanie krzyżowania nóg podczas siedzenia

4546

Profilaktyka podczas ciąży

Kobiety w ciąży i w okresie poporodowym mają zwiększone ryzyko ZŻG. W przypadku kobiet w ciąży z określonymi czynnikami ryzyka, można zalecić stosowanie leków lub innych metod zapobiegających ZŻG47.

Należy rozważyć profilaktyczną antykoagulację heparyną drobnocząsteczkową w okresie ciąży i po porodzie, opierając się na czynnikach ryzyka i wspólnym podejmowaniu decyzji48.

Skuteczność profilaktyki ZŻG

Zapobieganie ZŻG znacząco zmniejsza ryzyko zatorowości płucnej i śmiertelność. Stosowanie profilaktyki ZŻG może zmniejszyć częstość występowania ZŻG w okresie pooperacyjnym o dwie trzecie i zapobiec śmierci z powodu zatorowości płucnej u 1 pacjenta na każde 200 dużych operacji49.

Niestety, tylko około 50% hospitalizowanych pacjentów otrzymuje profilaktykę ZŻG, mimo że jej stosowanie znacząco zmniejsza ryzyko ZŻG i zatorowości płucnej, obniżając śmiertelność i chorobowość5051.

Skuteczność profilaktyki ZŻG zależy od wielu czynników, w tym od odpowiedniej oceny ryzyka, wyboru właściwej metody profilaktyki, czasu jej rozpoczęcia i czasu trwania52.

Interdyscyplinarne podejście do profilaktyki ZŻG

Praca zespołowa jest niezbędna w zapobieganiu ZŻG u pacjentów hospitalizowanych. Dobra komunikacja między lekarzami prowadzącymi, chirurgami (w przypadku pacjentów chirurgicznych), personelem pielęgniarskim i farmaceutami jest kluczowa dla zastosowania odpowiednich metod profilaktyki53.

Systemy decyzyjne oparte na komputerach i predefiniowane zlecenia są najbardziej skuteczne w optymalizacji przestrzegania przez lekarzy wytycznych dotyczących profilaktyki przeciwzakrzepowej. Okresowe audyty prowadzone przez farmaceutów lub innych pracowników służby zdrowia wzmacniają spójne stosowanie profilaktyki ZŻG54.

Tabela porównawcza metod profilaktyki ZŻG

Metoda profilaktyki Wskazania Zalety Wady Skuteczność
Heparyna drobnocząsteczkowa (LMWH) Pacjenci hospitalizowani, po zabiegach chirurgicznych, z wysokim ryzykiem ZŻG Skuteczna, jednokrotne podanie na dobę, mniejsze ryzyko małopłytkowości indukowanej heparyną Konieczność iniekcji, ryzyko krwawienia Wysoka
Heparyna niefrakcjonowana (UFH) Pacjenci z niewydolnością nerek, hospitalizowani Niski koszt, możliwość szybkiego odwrócenia działania Konieczność podawania 2-3 razy dziennie, większe ryzyko HIT Średnia
Fondaparinux Pacjenci po zabiegach ortopedycznych Jednokrotne podanie na dobę, brak ryzyka HIT Konieczność iniekcji, ryzyko krwawienia, przeciwwskazany przy ciężkiej niewydolności nerek Wysoka
Doustne antykoagulanty bezpośrednie (DOAC) Pacjenci po zabiegach ortopedycznych, hospitalizowani Doustne podanie, brak konieczności monitorowania Wyższy koszt, ograniczone możliwości odwrócenia działania Wysoka
Warfaryna Pacjenci po zabiegach ortopedycznych Doustne podanie, niski koszt Konieczność monitorowania INR, wiele interakcji lekowych Średnia do wysokiej
Aspiryna Pacjenci po zabiegach ortopedycznych z niskim ryzykiem ZŻG Doustne podanie, niski koszt Mniejsza skuteczność niż antykoagulanty Niska do średniej
Pończochy uciskowe Pacjenci z przeciwwskazaniami do antykoagulacji, podróżni Brak ryzyka krwawienia, łatwe w użyciu Mniejsza skuteczność niż antykoagulanty, problemy z dopasowaniem Niska do średniej
Przerywana kompresja pneumatyczna (IPC) Pacjenci z wysokim ryzykiem krwawienia, po zabiegach chirurgicznych Brak ryzyka krwawienia, poprawa przepływu krwi Ograniczona mobilność, dyskomfort, konieczność stosowania w szpitalu Średnia
Wczesna mobilizacja Wszyscy pacjenci hospitalizowani Brak kosztów, brak działań niepożądanych Nie zawsze możliwa, niewystarczająca jako jedyna metoda w wysokim ryzyku Niska do średniej

5556575859

Podsumowanie

Profilaktyka zakrzepicy żył głębokich jest kluczowym elementem opieki nad pacjentami hospitalizowanymi, poddawanymi zabiegom chirurgicznym oraz osobami z czynnikami ryzyka. Zastosowanie odpowiednich metod profilaktycznych, zarówno farmakologicznych, jak i mechanicznych, może znacząco zmniejszyć ryzyko ZŻG i jej powikłań, w tym zatorowości płucnej.

Skuteczna profilaktyka wymaga indywidualnej oceny ryzyka, dostosowania metod profilaktycznych do potrzeb pacjenta oraz interdyscyplinarnej współpracy zespołu medycznego. Wczesna mobilizacja, stosowanie antykoagulantów oraz metod kompresji mechanicznej stanowią podstawę działań profilaktycznych606162.

Pacjenci powinni również być edukowani na temat czynników ryzyka ZŻG oraz metod jej zapobiegania, zarówno w trakcie hospitalizacji, jak i po wypisie ze szpitala. Zmiany stylu życia, takie jak regularna aktywność fizyczna, utrzymywanie prawidłowej masy ciała, odpowiednie nawodnienie oraz unikanie palenia tytoniu, mogą przyczynić się do zmniejszenia ryzyka ZŻG w perspektywie długoterminowej63.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises. […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods.
  • #2 Deep Venous Thrombosis Prophylaxis – PubMed
    https://pubmed.ncbi.nlm.nih.gov/30521286/
    Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT is a major preventable cause of mortality and morbidity worldwide. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT.
  • #3 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Hospitalized patients are at increased risk of VTE when compared to patients in the community. Therefore, DVT prophylaxis should be considered in every hospitalized patient. […] Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE.
  • #4 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Hospitalized patients are at increased risk of VTE when compared to patients in the community. Therefore, DVT prophylaxis should be considered in every hospitalized patient. […] Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE.
  • #5 Venous Thromboembolism – Clinical Features – Management – TeachMeSurgery
    https://teachmesurgery.com/perioperative/cardiorespiratory/venous-thromboembolism/
    All patients being admitted to the hospital or undergoing surgery should be assessed for VTE risk on admission and re-assessed within 24 hours or if a change occurs in the clinical situation. […] An important part of the management of VTE is prophylaxis. Prophylaxis is typically continued until the patient is no longer considered to be at significant risk of VTE. […] All patients undergoing surgery should be offered mechanical prophylaxis unless otherwise contraindicated; mechanical prophylaxis (antiembolic stockings) should not be used in patients with peripheral arterial disease, peripheral oedema, or local skin conditions. […] There are two main methods of thromboprophylaxis used in hospital: Mechanical Thromboprophylaxis and Pharmacological Thromboprophylaxis. […] For cancer patients undergoing surgery, often they require prolonged period of post-operative prophylaxis (up to 1 month). […] A VTE risk assessment should be done on all patients. […] Patients at risk of VTE should be commenced on appropriate thromboprophylaxis. […] Patients with a confirmed VTE require prompt treatment with anticoagulants.
  • #6 11 Tips for DVT Prevention – Preferred Vascular Group
    https://preferredvasculargroup.com/dvt-prevention-tips/
    Deep vein thrombosis (DVT) is a condition in which a blood clot forms in one of the deep veins of your body. They usually occur in the legs. […] To decrease your risk of developing a blood clot in a deep vein, follow these tips for DVT prevention. […] One of the best tips for DVT prevention is to know whether or not you are at risk for the condition. […] The following factors can increase the chances of DVT: Surgery, Trauma, Sitting for long periods of time, Blood clotting disorder, Obesity, Pregnancy the first 4-6 weeks after giving birth, Varicose veins, Smoking, Heart failure, Inflammatory bowel disease, Increasing age, Kidney disease, Cancer and cancer therapy, Hormone therapy (birth control, hormone replacement), A pacemaker or a tube in a vein, History of DVT. […] Many of us sit at desks all day for work, which can increase the risk of deep vein thrombosis. […] If you do work in an office setting, try to find ways to keep moving throughout the day.
  • #7 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] This activity reviews the causes of DVT and highlights the role of the interprofessional team in the prophylaxis against DVT. […] Develop strategies to increase compliance with the use of DVT prophylaxis. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT.
  • #8 Deep Venous Thrombosis Prophylaxis – PubMed
    https://pubmed.ncbi.nlm.nih.gov/30521286/
    Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT is a major preventable cause of mortality and morbidity worldwide. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT.
  • #9 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] This activity reviews the causes of DVT and highlights the role of the interprofessional team in the prophylaxis against DVT. […] Develop strategies to increase compliance with the use of DVT prophylaxis. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT.
  • #10 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Hospitalized patients are at increased risk of VTE when compared to patients in the community. Therefore, DVT prophylaxis should be considered in every hospitalized patient. […] Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE.
  • #11 Deep Venous Thrombosis Prophylaxis (DVT Prophylaxis) – MD Searchlight
    https://mdsearchlight.com/preventive-medicine/deep-venous-thrombosis-prophylaxis-dvt-prophylaxis/
    Proactive measures to prevent these clots, or deep vein thrombosis (DVT) prophylaxis, should be considered for every patient staying in a hospital. […] To decide the best preventive measures, patients at risk of developing clots (thrombosis) are categorized into three groups: Low-risk patients, Moderate-risk patients, High-risk patients. […] Various drugs are commonly used to prevent clots in hospitalized patients and include low-molecular-weight heparins (LMWH), unfractionated heparin (UFH), and fondaparinux. […] Direct oral anticoagulants, a new type of blood thinner, have also been shown to reduce death rates among hospitalized patients, with betrixaban and rivaroxaban being approved for use in the hospital setting. […] Long-distance travelers who have a risk of VTE are recommended to wear properly fitted, below-knee compression stockings that apply 15-30 mm Hg of pressure.
  • #12 Venous Thromboembolism Prophylaxis | eCQI Resource Center
    https://ecqi.healthit.gov/ecqm/eh/2024/cms0108v12
    This measure assesses the number of patients who received Venous Thromboembolism (VTE) prophylaxis or have documentation why no VTE prophylaxis was given between the day of arrival to the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission. […] American Society of Hematology (ASH) 2018 VTE prophylaxis guidelines strongly recommend pharmacological prophylaxis using unfractionated heparin (UFH), low molecular weight heparin (LMWH) or fondaparinux for acutely and critically ill hospitalized medical patients, unless contraindicated. The use of mechanical prophylaxis is an acceptable alternative for patients with increased risk of bleeding and preferred over no prophylaxis. ASH 2019 guidelines for surgical patients similarly recommend pharmacological or mechanical prophylaxis over no VTE prophylaxis.
  • #13 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention
    It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk. DVT prophylaxis begins with risk assessment. Preventive measures include prevention of immobility, prophylactic anticoagulation, and intermittent pneumatic compression. Patients at low risk of DVT should be encouraged to walk or otherwise move their legs periodically; no medical treatment is needed. Patients at higher risk of DVT require additional preventive treatment. Most of these patients can be identified and should receive DVT prophylaxis. DVT prophylaxis can involve one or more of the following: mechanical therapy and pharmacologic therapy. The benefit of graded compression stockings is questionable except for low-risk surgical patients and selected hospitalized medical patients. However, combining stockings with other preventive measures may be more protective than any single approach. For patients who are at very high risk of DVT and bleeding, IPC is recommended until the bleeding risk subsides and anticoagulants can be given. The use of inferior vena cava filters should be avoided unless DVT has been confirmed, except in highly selected patients. For hip and other lower extremity orthopedic surgery, selected direct oral anticoagulants, LMWH, fondaparinux, or adjusted-dose warfarin is recommended. Preventive treatment is also indicated for patients who have major medical illnesses that require bed rest. Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated. In patients with symptomatic DVT who develop symptoms of post-thrombotic syndrome, the use of knee-high compression stockings providing 30 to 40 mm Hg pressure is recommended. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings.
  • #14 Deep vein thrombosis – Knowledge @ AMBOSS
    https://www.amboss.com/us/knowledge/deep-vein-thrombosis/
    Prophylaxis is usually indicated in seriously ill patients who are hospitalized, patients undergoing major surgery, patients with major trauma, and long-distance travelers with additional risk factors for VTE. […] In surgical patients, the first dose of the antithrombotic should be administered within 12 hours of completing the surgery. […] LMWH or low-dose UFH is recommended for postoperative anticoagulation in patients who have undergone major surgery. […] Consider prophylactic anticoagulation with LMWH based on risk factors and shared decision-making in pregnancy and postpartum.
  • #15 Deep Vein Thrombosis Prevention
    https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm
    Early mobilization after surgery is critical […] Most non-surgical patients do not require DVT Prophylaxis after discharge (unless VTE or other indication) […] Anticoagulation start varies per medication and risk […] Continue Anticoagulation for at least 10 to 14 days post-orthopedic surgery […] Indications for extended Anticoagulation (28-35 days) […] Anticoagulation options […] Low Molecular Weight Heparin […] Warfarin with target INR 2-3 […] Aspirin (not a first-line agent) […] However, Low Molecular Weight Heparin is much more effective […] Additional strategies (with Anticoagulation) […] Special circumstances: Prophylaxis after Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA) […] Duration of DVT Prophylaxis (may be adjusted for mobility) […] Low Molecular Weight Heparin (e.g. Enoxaparin or Lovenox)
  • #16 Deep Vein Thrombosis Prevention
    https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm
    Compared with LMWH, Apixaban has equivalent efficacy in DVT Prophylaxis […] Compared with LMWH, prevents 4 more DVTs […] Aspirin […] Do not use Aspirin prophylaxis in high risk patients (e.g. prior VTE, active cancer, immobile) […] Special circumstances: Hip Fracture protocol […] Continue for at least 10-14 days after surgery […] Consider continuing for 28 to 35 days post-op […] Special circumstances: Elective hip surgery […] Ambulation before the second post-surgical day […] Management: Thromboprophylaxis in Critical Illness and Major Trauma […] Start within 12-24 hours of major Trauma or when otherwise hemodynamically stable without active bleeding […] Low Molecular Weight Heparin (LMWH or Enoxaparin or Lovenox) […] Standard dose: 40 mg every 24 hours […] Very high VTE Risk: 30 mg SC every 12 hours
  • #17 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Hospitalized patients are at increased risk of VTE when compared to patients in the community. Therefore, DVT prophylaxis should be considered in every hospitalized patient. […] Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE.
  • #18 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
    https://emedicine.medscape.com/article/1268573-overview
    Mechanical methods have been shown to be a useful adjunct to anticoagulation therapy in reducing the incidence of DVT. Modalities include passive devices, such as knee- or thigh-high graduated compression (elastic) stockings; active (external pneumatic compress or intermittent pneumatic compression [IPC]) devices; or venous foot pumps (VFP). A 2012 systematic review of randomized, controlled trials found that knee- and thigh-high GCS do not significantly differ in their effectiveness in reducing the incidence of DVT in hospitalized patients. In a study of the efficacy of IPC in multiple postoperative patient groups versus no use of prophylaxis, Urbankova et al reported that the incidence of DVT was reduced by 60%. However, the use of mechanical means of prophylaxis alone is not effective in moderate or high-risk cases. IPC devices are designed to decrease venous stasis, improve blood flow velocity, and increase the level of circulating fibrinolysins. These devices have the advantage of requiring no monitoring, with no increase in bleeding. Generally, they are well tolerated. Various forms of IPC devices are available, and they can be applied to the foot, calf, or thigh. Although all three types of mechanical compression reduce the incidence of DVT to less than that found when prophylaxis is absent, these modalities are generally less effective at producing such reductions than pharmacologic methods are. Shorter hospital stays make the use of mechanical methods alone ineffective in preventing DVT in the critical weeks after joint replacement. No mechanical prophylaxis method has been shown to reduce the risk of PE or death. The use of IPC devices is therefore recommended primarily as an adjunct to anticoagulant-based prophylaxis or in patients who are at high risk of bleeding.
  • #19 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention
    It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk. DVT prophylaxis begins with risk assessment. Preventive measures include prevention of immobility, prophylactic anticoagulation, and intermittent pneumatic compression. Patients at low risk of DVT should be encouraged to walk or otherwise move their legs periodically; no medical treatment is needed. Patients at higher risk of DVT require additional preventive treatment. Most of these patients can be identified and should receive DVT prophylaxis. DVT prophylaxis can involve one or more of the following: mechanical therapy and pharmacologic therapy. The benefit of graded compression stockings is questionable except for low-risk surgical patients and selected hospitalized medical patients. However, combining stockings with other preventive measures may be more protective than any single approach. For patients who are at very high risk of DVT and bleeding, IPC is recommended until the bleeding risk subsides and anticoagulants can be given. The use of inferior vena cava filters should be avoided unless DVT has been confirmed, except in highly selected patients. For hip and other lower extremity orthopedic surgery, selected direct oral anticoagulants, LMWH, fondaparinux, or adjusted-dose warfarin is recommended. Preventive treatment is also indicated for patients who have major medical illnesses that require bed rest. Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated. In patients with symptomatic DVT who develop symptoms of post-thrombotic syndrome, the use of knee-high compression stockings providing 30 to 40 mm Hg pressure is recommended. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings.
  • #20 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
    https://emedicine.medscape.com/article/1268573-overview
    Mechanical methods have been shown to be a useful adjunct to anticoagulation therapy in reducing the incidence of DVT. Modalities include passive devices, such as knee- or thigh-high graduated compression (elastic) stockings; active (external pneumatic compress or intermittent pneumatic compression [IPC]) devices; or venous foot pumps (VFP). A 2012 systematic review of randomized, controlled trials found that knee- and thigh-high GCS do not significantly differ in their effectiveness in reducing the incidence of DVT in hospitalized patients. In a study of the efficacy of IPC in multiple postoperative patient groups versus no use of prophylaxis, Urbankova et al reported that the incidence of DVT was reduced by 60%. However, the use of mechanical means of prophylaxis alone is not effective in moderate or high-risk cases. IPC devices are designed to decrease venous stasis, improve blood flow velocity, and increase the level of circulating fibrinolysins. These devices have the advantage of requiring no monitoring, with no increase in bleeding. Generally, they are well tolerated. Various forms of IPC devices are available, and they can be applied to the foot, calf, or thigh. Although all three types of mechanical compression reduce the incidence of DVT to less than that found when prophylaxis is absent, these modalities are generally less effective at producing such reductions than pharmacologic methods are. Shorter hospital stays make the use of mechanical methods alone ineffective in preventing DVT in the critical weeks after joint replacement. No mechanical prophylaxis method has been shown to reduce the risk of PE or death. The use of IPC devices is therefore recommended primarily as an adjunct to anticoagulant-based prophylaxis or in patients who are at high risk of bleeding.
  • #21 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
    https://emedicine.medscape.com/article/1268573-overview
    Mechanical methods have been shown to be a useful adjunct to anticoagulation therapy in reducing the incidence of DVT. Modalities include passive devices, such as knee- or thigh-high graduated compression (elastic) stockings; active (external pneumatic compress or intermittent pneumatic compression [IPC]) devices; or venous foot pumps (VFP). A 2012 systematic review of randomized, controlled trials found that knee- and thigh-high GCS do not significantly differ in their effectiveness in reducing the incidence of DVT in hospitalized patients. In a study of the efficacy of IPC in multiple postoperative patient groups versus no use of prophylaxis, Urbankova et al reported that the incidence of DVT was reduced by 60%. However, the use of mechanical means of prophylaxis alone is not effective in moderate or high-risk cases. IPC devices are designed to decrease venous stasis, improve blood flow velocity, and increase the level of circulating fibrinolysins. These devices have the advantage of requiring no monitoring, with no increase in bleeding. Generally, they are well tolerated. Various forms of IPC devices are available, and they can be applied to the foot, calf, or thigh. Although all three types of mechanical compression reduce the incidence of DVT to less than that found when prophylaxis is absent, these modalities are generally less effective at producing such reductions than pharmacologic methods are. Shorter hospital stays make the use of mechanical methods alone ineffective in preventing DVT in the critical weeks after joint replacement. No mechanical prophylaxis method has been shown to reduce the risk of PE or death. The use of IPC devices is therefore recommended primarily as an adjunct to anticoagulant-based prophylaxis or in patients who are at high risk of bleeding.
  • #22 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
    https://emedicine.medscape.com/article/1268573-overview
    Mechanical methods have been shown to be a useful adjunct to anticoagulation therapy in reducing the incidence of DVT. Modalities include passive devices, such as knee- or thigh-high graduated compression (elastic) stockings; active (external pneumatic compress or intermittent pneumatic compression [IPC]) devices; or venous foot pumps (VFP). A 2012 systematic review of randomized, controlled trials found that knee- and thigh-high GCS do not significantly differ in their effectiveness in reducing the incidence of DVT in hospitalized patients. In a study of the efficacy of IPC in multiple postoperative patient groups versus no use of prophylaxis, Urbankova et al reported that the incidence of DVT was reduced by 60%. However, the use of mechanical means of prophylaxis alone is not effective in moderate or high-risk cases. IPC devices are designed to decrease venous stasis, improve blood flow velocity, and increase the level of circulating fibrinolysins. These devices have the advantage of requiring no monitoring, with no increase in bleeding. Generally, they are well tolerated. Various forms of IPC devices are available, and they can be applied to the foot, calf, or thigh. Although all three types of mechanical compression reduce the incidence of DVT to less than that found when prophylaxis is absent, these modalities are generally less effective at producing such reductions than pharmacologic methods are. Shorter hospital stays make the use of mechanical methods alone ineffective in preventing DVT in the critical weeks after joint replacement. No mechanical prophylaxis method has been shown to reduce the risk of PE or death. The use of IPC devices is therefore recommended primarily as an adjunct to anticoagulant-based prophylaxis or in patients who are at high risk of bleeding.
  • #23 Prevention and Treatment of Venous Thromboembolism | American Heart Association
    https://www.heart.org/en/health-topics/venous-thromboembolism/prevention-and-treatment-of-venous-thromboembolism-vte
    Be proactive. Ask for a risk assessment for VTE if you are admitted to the hospital or are having surgery. […] VTEs often are preventable, with strategies that stop the development of clots in people „at-risk.” […] Those at risk may take anti-clotting, or blood-thinning, medications or use mechanical devices such as compression stockings or compression devices. […] Getting out of bed quickly after surgery is also advised if possible. […] Keep moving. Move around when you are able to or as encouraged by your health care professional. […] Consider compression. Use graduated compression stockings or massaging compression devices if recommended by your health care professional. […] Take prescribed medication. If you have a high risk of a blood clot and a low risk of bleeding, a low-dose, “blood-thinning” medicine may help.
  • #24 Prevention of Deep Vein Thrombosis | Stanford Health Care
    https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/deep-vein-thrombosis/treatments/prevention.html
    Preventing deep vein thrombosis is important to prevent pulmonary embolism, which can lead to serious complications. […] Medications, such as anticoagulants, may be given to certain surgical patients to prevent deep vein thrombosis. Those patients who have had a previous clot should follow the instructions of their physician. […] Preventing deep vein thrombosis caused by long periods of sitting or reclining involves moving the lower leg. Flexing (bending) the knees may be helpful. […] Other preventative measures may include: […] Getting up and moving as soon as possible after surgery or illness, as movement can help to prevent clots from forming by stimulating blood circulation […] A pneumatic compression device, which looks like a special fitted sleeve, placed on the legs to help keep blood moving during some types of surgery […] Elastic stockings to reduce swelling and promote circulation.
  • #25 Preventing Deep Vein Thrombosis After Surgery | Saint Luke’s Health System
    https://www.saintlukeskc.org/health-library/preventing-deep-vein-thrombosis-after-surgery
    In the days and weeks after surgery, you have a higher chance of developing a deep vein thrombosis (DVT). […] Your healthcare provider will usually prescribe one or more of the following to prevent blood clots: […] This medicine prevents blood clots. […] These elastic stockings fit tightly around your legs. They help keep blood flowing toward your heart by the pressure they apply. […] Simple exercises while you are resting in bed or sitting in a chair can help prevent blood clots. […] After surgery, a nurse will help you out of bed as soon as you are able. Moving around improves circulation and helps prevent blood clots. […] Plastic sleeves are wrapped around your legs and connected to a pump that inflates and deflates the sleeves. This applies gentle pressure to promote blood flow in the legs and prevent blood clots.
  • #26 Preventing Deep Vein Thrombosis After Surgery | Saint Luke’s Health System
    https://www.saintlukeskc.org/health-library/preventing-deep-vein-thrombosis-after-surgery
    Deep vein thrombosis can happen even after you go home. […] If a blood thinner was prescribed, make sure you follow all directions about taking it. […] Your healthcare provider will tell you how often to wear and remove the stockings. […] Follow all instructions about returning to activities. Be as active as you can. This improves blood flow and helps prevent a clot from forming. […] In some cases, this device may be recommended at home.
  • #27 DVT (deep vein thrombosis)
    https://www.nhs.uk/conditions/deep-vein-thrombosis-dvt/
    There are things you can do to lower your chance of getting DVT (deep vein thrombosis). […] stay a healthy weight […] stay active taking regular walks can help […] drink plenty of fluids to avoid dehydration DVT is more likely if you’re dehydrated […] do not sit still for long periods of time get up and move around every hour or so […] do not cross your legs while you’re sitting […] do not smoke […] do not drink lots of alcohol […] If you’re travelling for 3 hours or more by plane, train or car, there are things you can do during the journey to lower your chances of getting DVT. […] If you go into hospital, your healthcare team should check if there’s a higher chance you’ll get DVT. […] If they think you’re more likely to get DVT, you may be given treatment to prevent it, such as medicine or compression stockings (knee-high elastic socks that help your blood circulation), while you’re in hospital. […] You may continue treatment after you leave hospital because a blood clot can happen weeks later.
  • #28 Deep vein thrombosis – Wikipedia
    https://en.wikipedia.org/wiki/Deep_vein_thrombosis
    Traveling „is an often cited yet relatively uncommon” cause of VTE. Suggestions for at-risk long-haul travelers include calf exercises, frequent walking, and aisle seating in airplanes to ease walking. Graduated compression stockings have sharply reduced the levels of asymptomatic DVT in airline passengers, but the effect on symptomatic DVT, PE, or mortality is unknown, as none of the individuals studied developed these outcomes. However, graduated compression stockings are not suggested for long-haul travelers (4 hours) without risk factors for VTE. Likewise, neither aspirin nor anticoagulants are suggested in the general population undertaking long-haul travel. Those with significant VTE risk factors undertaking long-haul travel are suggested to use either graduated compression stockings or LMWH for VTE prevention. If neither of these two methods are feasible, then aspirin is suggested.
  • #29 Patient education: Deep vein thrombosis (DVT) (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/deep-vein-thrombosis-dvt-beyond-the-basics
    In all cases, walking as soon as possible after surgery can decrease the risk of a blood clot; it can also decrease the risk of chronic swelling in the legs from your DVT (also known as „post-thrombotic syndrome”). […] […] Extended travel — Prolonged travel (eg, taking an airplane flight or car ride that lasts more than five hours) appears to increase the risk of developing blood clots, although the risk is very small. There are a few tips that may be of benefit during extended travel (table 1).
  • #30 DVT Prevention & Home Care: How To Prevent Deep Vein Thrombosis
    https://www.webmd.com/dvt/deep-vein-thrombosis-prevent-dvt
    A DVT is a blood clot that forms deep in your veins, most often in your leg. It can partially or completely block blood flow back to the heart and damage the one-way valves in your veins. It can also break free and travel to major organs, such as your lungs, which can be very dangerous. […] Even if you’re at risk, you can take steps to prevent DVT. Some simple actions include: […] Exercise regularly — daily, if possible. Walking, swimming, and bicycling are all great activities. Exercise will also help you manage your weight, and so will eating a healthy, high-fiber diet with lots of vegetables and fruits. […] Your doctor may prescribe blood thinners, also called anticoagulants: […] You may want to wear compression sleeves on your legs to help keep your blood flowing. […] On flights longer than 4 hours, get up and move around. Take the opportunity to walk and stretch between connecting flights, too. […] Drink plenty of fluids, but avoid coffee and alcohol. They’ll dehydrate you, which makes your veins narrower and blood thicker, so you’re more likely to get a clot. […] You might want to wear compression stockings. They’ll help your blood flow and keep swelling down.
  • #31 Deep vein thrombosis (DVT) – Symptoms & causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/deep-vein-thrombosis/symptoms-causes/syc-20352557
    Lifestyle changes may help prevent deep vein thrombosis. Try these strategies: […] Move your legs. If you’ve had surgery or have been on bed rest, try to move as soon as possible. Don’t cross your legs while sitting. Doing so can block blood flow. […] When traveling, take frequent breaks to stretch your legs. When on a plane, stand or walk occasionally. If you’re traveling by car, stop every hour or so and walk around. If you can’t walk, do lower leg exercises. Raise and lower your heels while keeping your toes on the floor. Then raise your toes while keeping your heels on the floor. […] Don’t smoke. Smoking increases the risk of DVT. […] Manage weight. Obesity is a risk factor for DVT. Regular exercise lowers the risk of blood clots. As a general goal, aim for at least 30 minutes of moderate physical activity every day. If you want to lose weight, maintain weight loss or meet specific fitness goals, you may need to exercise more.
  • #32 Prevention and Treatment of Venous Thromboembolism | American Heart Association
    https://www.heart.org/en/health-topics/venous-thromboembolism/prevention-and-treatment-of-venous-thromboembolism-vte
    Perform simple exercises. Flex and extend the ankles and knees and contract the calf muscles at regular intervals. […] Walk around. Get up and walk while traveling every hour. […] Consider compression. Wear compression socks during your travel. […] Change positions while seated and avoid crossing your legs. […] Avoid alcohol and hydrate with water.
  • #33 How to prevent DVT when travelling: Deep Vein Thrombosis
    https://patient.info/allergies-blood-immune/deep-vein-thrombosis-leaflet/preventing-dvt-when-you-travel
    This leaflet advises on how to reduce the risk of a deep vein thrombosis occurring during a long journey. […] How to reduce the risk of DVT when travelling […] Exercise your calf and foot muscles regularly: […] Every half hour or so, bend and straighten your legs, feet and toes when you are seated. […] Press the balls of your feet down hard against the floor or footrest every so often. This helps to increase the blood flow in your legs. […] Take a walk up and down the aisle every hour or so, when it is safe to do so. […] Make sure you have as much space as possible in front of you for your legs to move. So avoid having bags under the seat in front of you and recline your seat where possible. […] Take all opportunities to get up to stretch your legs, when there are stops in your journey.
  • #34 Deep Vein Thrombosis and Pulmonary Embolism | Yellow Book | CDC
    https://wwwnc.cdc.gov/travel/yellowbook/2024/air-land-sea/deep-vein-thrombosis-and-pulmonary-embolism
    For long-distance travelers (6 hours travel) at increased risk of VTE, the ACCP recommends frequent ambulation, calf muscle exercise, sitting in an aisle seat, and using properly fitted below-the-knee GCS that provide 15-30 mmHg of pressure at the ankle during travel. […] For long-distance travelers (4 hours travel) at substantially increased VTE risk (e.g., recent surgery, prior history of VTE, postpartum, active malignancy, or 2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), the ASH guidelines suggest GCS or prophylactic LMWH.
  • #35 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Hospitalized patients are at increased risk of VTE when compared to patients in the community. Therefore, DVT prophylaxis should be considered in every hospitalized patient. […] Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE.
  • #36 Patient education: Deep vein thrombosis (DVT) (Beyond the Basics) – UpToDate
    https://www.uptodate.com/contents/deep-vein-thrombosis-dvt-beyond-the-basics
    DEEP VEIN THROMBOSIS PREVENTION […] People with cancer — In selected situations, such as in people undergoing treatment for cancer who are at high risk for DVT (eg, people with stomach or pancreatic cancer who are receiving chemotherapy), anticoagulants may be considered for use to prevent a DVT from occurring. […] […] During hospitalization — Some people who are in the hospital, either for surgery (especially bone or joint surgery and cancer surgery) or because of a serious medical illness, may be given anticoagulants to decrease the risk of blood clots. Anticoagulants may also be given to female patients at high risk for venous thrombosis during and after pregnancy. (See 'Deep vein thrombosis risk factors’ above.) […] […] In people who are hospitalized and have a moderate to low risk of blood clots, other preventive measures may be used. For example, some people are fitted with inflatable compression devices after surgery. These devices are worn around the legs during and immediately after surgery and periodically fill with air. These devices apply gentle pressure to improve circulation and help prevent clots. Compression stockings may also be recommended. […]
  • #37 Deep vein thrombosis – Wikipedia
    https://en.wikipedia.org/wiki/Deep_vein_thrombosis
    Major orthopedic surgerytotal hip replacement, total knee replacement, or hip fracture surgeryhas a high risk of causing VTE. If prophylaxis is not used after these surgeries, symptomatic VTE has about a 4% chance of developing within 35 days. Following major orthopedic surgery, a blood thinner or aspirin is typically paired with intermittent pneumatic compression, which is the preferred mechanical prophylaxis over graduated compression stockings. Options for VTE prevention in people following non-orthopedic surgery include early walking, mechanical prophylaxis, and blood thinners (low-molecular-weight heparin and low-dose-unfractionated heparin) depending upon the risk of VTE, risk of major bleeding, and person’s preferences. After low-risk surgeries, early and frequent walking is the best preventive measure.
  • #38 Deep vein thrombosis – Wikipedia
    https://en.wikipedia.org/wiki/Deep_vein_thrombosis
    Major orthopedic surgerytotal hip replacement, total knee replacement, or hip fracture surgeryhas a high risk of causing VTE. If prophylaxis is not used after these surgeries, symptomatic VTE has about a 4% chance of developing within 35 days. Following major orthopedic surgery, a blood thinner or aspirin is typically paired with intermittent pneumatic compression, which is the preferred mechanical prophylaxis over graduated compression stockings. Options for VTE prevention in people following non-orthopedic surgery include early walking, mechanical prophylaxis, and blood thinners (low-molecular-weight heparin and low-dose-unfractionated heparin) depending upon the risk of VTE, risk of major bleeding, and person’s preferences. After low-risk surgeries, early and frequent walking is the best preventive measure.
  • #39 Deep Vein Thrombosis – OrthoInfo – AAOS
    https://orthoinfo.aaos.org/en/diseases–conditions/deep-vein-thrombosis/
    Deep vein thrombosis, or DVT, occurs when a blood clot forms in one of the deep veins of the body. […] For this reason, doctors focus on preventing the development of DVT using different types of therapies, depending upon a patient’s needs. Your doctor will take steps to prevent DVT if you have a major fracture or are having lower extremity surgery including total hip or total knee replacement. […] The measures your doctor uses to help prevent DVT are called prophylaxis. The doctor will use several preventive measures in combination. For example, if you are having total knee or total hip replacement, your doctor may prescribe: Early movement and exercise, Compression stockings, Medications that thin the blood and reduce the body’s ability to form blood clots. […] Most patients begin walking or doing other leg exercises as soon as possible after surgery. Performing simple leg lifts while lying in bed will help increase blood flow through the veins.
  • #40 Deep Vein Thrombosis – OrthoInfo – AAOS
    https://orthoinfo.aaos.org/en/diseases–conditions/deep-vein-thrombosis/
    Graded elastic compression stockings are tight at the ankle and become looser as they go up the leg. The compression they provide may help circulation by preventing blood from pooling in the veins. […] Anticoagulants, or blood thinners, are used to stop blood clots from getting bigger and to prevent new blood clots from forming. If you are having joint replacement surgery, you will start anticoagulants the day after surgery and continue in the hospital and at home.
  • #41 Deep Vein Thrombosis Prevention
    https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm
    Early mobilization after surgery is critical […] Most non-surgical patients do not require DVT Prophylaxis after discharge (unless VTE or other indication) […] Anticoagulation start varies per medication and risk […] Continue Anticoagulation for at least 10 to 14 days post-orthopedic surgery […] Indications for extended Anticoagulation (28-35 days) […] Anticoagulation options […] Low Molecular Weight Heparin […] Warfarin with target INR 2-3 […] Aspirin (not a first-line agent) […] However, Low Molecular Weight Heparin is much more effective […] Additional strategies (with Anticoagulation) […] Special circumstances: Prophylaxis after Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA) […] Duration of DVT Prophylaxis (may be adjusted for mobility) […] Low Molecular Weight Heparin (e.g. Enoxaparin or Lovenox)
  • #42 Deep Vein Thrombosis Prevention
    https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm
    Compared with LMWH, Apixaban has equivalent efficacy in DVT Prophylaxis […] Compared with LMWH, prevents 4 more DVTs […] Aspirin […] Do not use Aspirin prophylaxis in high risk patients (e.g. prior VTE, active cancer, immobile) […] Special circumstances: Hip Fracture protocol […] Continue for at least 10-14 days after surgery […] Consider continuing for 28 to 35 days post-op […] Special circumstances: Elective hip surgery […] Ambulation before the second post-surgical day […] Management: Thromboprophylaxis in Critical Illness and Major Trauma […] Start within 12-24 hours of major Trauma or when otherwise hemodynamically stable without active bleeding […] Low Molecular Weight Heparin (LMWH or Enoxaparin or Lovenox) […] Standard dose: 40 mg every 24 hours […] Very high VTE Risk: 30 mg SC every 12 hours
  • #43 Deep vein thrombosis (DVT) – Symptoms & causes – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/deep-vein-thrombosis/symptoms-causes/syc-20352557
    Lifestyle changes may help prevent deep vein thrombosis. Try these strategies: […] Move your legs. If you’ve had surgery or have been on bed rest, try to move as soon as possible. Don’t cross your legs while sitting. Doing so can block blood flow. […] When traveling, take frequent breaks to stretch your legs. When on a plane, stand or walk occasionally. If you’re traveling by car, stop every hour or so and walk around. If you can’t walk, do lower leg exercises. Raise and lower your heels while keeping your toes on the floor. Then raise your toes while keeping your heels on the floor. […] Don’t smoke. Smoking increases the risk of DVT. […] Manage weight. Obesity is a risk factor for DVT. Regular exercise lowers the risk of blood clots. As a general goal, aim for at least 30 minutes of moderate physical activity every day. If you want to lose weight, maintain weight loss or meet specific fitness goals, you may need to exercise more.
  • #44 Preventing Deep Vein Thrombosis | NYU Langone Health
    https://nyulangone.org/conditions/deep-vein-thrombosis/prevention
    NYU Langone doctors advise people on how to avoid deep vein thrombosis, or DVT, a blood clot that usually forms in a leg. […] Certain factors increase a persons risk of developing deep vein thrombosis. […] Fortunately, some of these risk factors can be controlled. Leading an active lifestyle, avoiding tobacco, and staying as mobile as possible before and after surgery are all ways to decrease the risk of developing deep vein thrombosis. […] Physical activity promotes blood flow and may prevent deep vein thrombosis. […] Dehydration contributes to the development of sluggish blood flow and blood clots. […] Obesity puts additional pressure on the veins in your legs, which contributes to poor blood flow and the development of blood clots. […] One of the best ways to prevent a blood clot is to stop smoking or using any tobacco products. […] If you are using hormone replacement therapy or oral contraceptives and have other risk factors for deep vein thrombosis, your NYU Langone physician may advise you to avoid these medications.
  • #45 About Venous Thromboembolism (Blood Clots) | Venous Thromboembolism (Blood Clots) | CDC
    https://www.cdc.gov/blood-clots/about/index.html
    DVT and PE are serious but often preventable conditions. […] The good news is that VTE is often preventable and treatable. […] The following tips can help prevent DVT/PE: Move around as soon as possible after having been confined to bed, such as after surgery, illness, or injury. […] If you’re at risk for DVT/PE, talk to your doctor about: Graduated compression stockings (sometimes called „medical compression stockings”) […] Medication (anticoagulants) to prevent DVT/PE. […] When sitting for long periods of time, such as when traveling for more than 4 hours: Get up and walk around every 1 to 2 hours. […] You can also reduce your risk by maintaining a healthy weight, avoiding a sedentary lifestyle, and following your doctor’s recommendations based on your individual risk factors.
  • #46 Deep vein thrombosis (DVT) – symptoms, signs and treatment | healthdirect
    https://www.healthdirect.gov.au/deep-vein-thrombosis
    See your doctor immediately if you have signs of a deep vein thrombosis (red, swollen leg). Call triple zero (000) and ask for an ambulance if you have chest pain, trouble breathing or symptoms of stroke or heart attack. […] How can DVT be prevented? […] There are some steps you can take to help prevent DVTs. […] If you are travelling for hours (for example, on planes or trains), remember to: get up to walk around every hour or 2, do exercises like calf stretches or heel lifts, drink plenty of water, avoid alcohol or caffeine as these can add to dehydration, wear compression stockings if you have other DVT risk factors. […] When in hospital or recovering from illness, make sure that you: tell hospital staff if you have had DVT before, wear compression stockings, move your feet and legs when possible, even if you are unable to walk around, stay hydrated. […] If you have had DVT before, do your best to: quit smoking, keep fit, maintain a healthy weight.
  • #47 Preventing Deep Vein Thrombosis | ACOG
    https://www.acog.org/womens-health/faqs/preventing-deep-vein-thrombosis
    DVT can occur in anyone, but some factors can increase the risk. Having more than one risk factor further increases the risk. Events or conditions that increase the risk of DVT include the following: […] Your doctor may prescribe medications to prevent blood clots from forming before or after surgery. […] If you’re pregnant, medication or other treatments may be prescribed to prevent DVT if you have certain risk factors: […] When planning a long trip, the following preventive steps are recommended, especially if you are pregnant or have other risk factors for DVT: […] Special stockings that compress the legs below the knee may help prevent blood clots from forming.
  • #48 Deep vein thrombosis – Knowledge @ AMBOSS
    https://www.amboss.com/us/knowledge/deep-vein-thrombosis/
    Prophylaxis is usually indicated in seriously ill patients who are hospitalized, patients undergoing major surgery, patients with major trauma, and long-distance travelers with additional risk factors for VTE. […] In surgical patients, the first dose of the antithrombotic should be administered within 12 hours of completing the surgery. […] LMWH or low-dose UFH is recommended for postoperative anticoagulation in patients who have undergone major surgery. […] Consider prophylactic anticoagulation with LMWH based on risk factors and shared decision-making in pregnancy and postpartum.
  • #49 Best Practices Preventing Deep Vein Thrombosis and Pulmonary Embolism
    https://www.outcomes-umassmed.org/dvt/best_practice/
    For over a decade, we have been involved in projects to improve the use of prophylaxis for deep vein thrombosis (DVT) in Massachusetts hospitals. […] The tools provided in this manual will help you to create a structured quality improvement program that can assist physicians and hospital quality assurance managers in evaluating and improving the use of DVT prophylaxis. […] Implementation of a system-wide process for preventing DVT will also help your hospital meet the JCAHO requirement for quality improvement activities. […] Use of modern methods of DVT prophylaxis will reduce the incidence of DVT during the postoperative period by two-thirds and will prevent death from pulmonary embolism in 1 patient out of every 200 major operations. […] Using prophylaxis for DVT is neither complicated nor expensive.
  • #50 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] This activity reviews the causes of DVT and highlights the role of the interprofessional team in the prophylaxis against DVT. […] Develop strategies to increase compliance with the use of DVT prophylaxis. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT.
  • #51 Deep Venous Thrombosis Prophylaxis – PubMed
    https://pubmed.ncbi.nlm.nih.gov/30521286/
    Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT is a major preventable cause of mortality and morbidity worldwide. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT.
  • #52 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
    https://emedicine.medscape.com/article/1268573-overview
    Venous thromboembolism (VTE, including deep vein thrombosis [DVT] and pulmonary embolism [PE]) in surgical patients undergoing general anesthesia has been extensively studied. The risk of VTE remains high for up to 2 months after noncancer general surgery. Fatal PE rates range from 0.1% to 0.8% for all patients and may be as high as 7% for patients undergoing surgery for fractured hips. A study of patients with pelvic or lower-extremity fracture (N = 3295) by Pan et al found a 2.08% incidence of PE in patients with below-knee DVT and a 3.17% incidence in patients with above-knee DVT. In many patients who undergo foot and ankle surgery, DVT may develop without clinically apparent symptoms or signs. Many different forms of therapy have been evaluated in this group. Studies of pneumatic compression in cardiac surgery and neurosurgical patients have shown a distinct improvement in the incidence of DVT without the added risk of bleeding. However, the effect is less impressive in higher-risk patients, and compliance can be difficult. The timing and duration of pharmacologic prophylaxis have also been determined to exert a significant effect the development of DVT. Early prophylaxis in surgical patients with low-molecular-weight heparin (LMWH) has been associated with significant reductions in postoperative venous thrombosis. A study by Hull et al found that initiation of therapy within 8 hours of surgery had the greatest effect. The ninth edition of the clinical practice guidelines for prevention of VTE from the American College of Chest Physicians (ACCP) recommended that LMWH be given to patients undergoing major orthopedic procedures at least 12 hours preoperatively or postoperatively. In August 2024, updated European guidelines for prophylaxis of VTE in nonambulatory orthopedic surgery were published.
  • #53 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK534865/
    Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises. […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods.
  • #54 Venous thromboembolism (VTE) prophylaxis – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-gb/1087
    Thromboprophylaxis is the most important patient safety strategy in patients admitted to hospital. […] Although national and international thromboprophylaxis guidelines have repeatedly recommended thromboprophylaxis of patients admitted to hospital, only 40% to 50% of medical patients and 60% to 75% of surgical patients receive adequate thromboprophylaxis. […] Venous thromboembolism (VTE) prophylaxis consists of pharmacological and non-pharmacological measures to diminish the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). […] Computer-based decision systems and pre-printed orders are most effective in optimising physician adherence to thromboprophylaxis guidelines. Periodic audits by pharmacists or other health professionals reinforce the consistent use of venous thromboembolism prophylaxis.
  • #55 Deep Vein Thrombosis Prevention
    https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm
    Early mobilization after surgery is critical […] Most non-surgical patients do not require DVT Prophylaxis after discharge (unless VTE or other indication) […] Anticoagulation start varies per medication and risk […] Continue Anticoagulation for at least 10 to 14 days post-orthopedic surgery […] Indications for extended Anticoagulation (28-35 days) […] Anticoagulation options […] Low Molecular Weight Heparin […] Warfarin with target INR 2-3 […] Aspirin (not a first-line agent) […] However, Low Molecular Weight Heparin is much more effective […] Additional strategies (with Anticoagulation) […] Special circumstances: Prophylaxis after Total Knee Arthroplasty (TKA) or Total Hip Arthroplasty (THA) […] Duration of DVT Prophylaxis (may be adjusted for mobility) […] Low Molecular Weight Heparin (e.g. Enoxaparin or Lovenox)
  • #56 Deep Vein Thrombosis Prevention
    https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm
    Compared with LMWH, Apixaban has equivalent efficacy in DVT Prophylaxis […] Compared with LMWH, prevents 4 more DVTs […] Aspirin […] Do not use Aspirin prophylaxis in high risk patients (e.g. prior VTE, active cancer, immobile) […] Special circumstances: Hip Fracture protocol […] Continue for at least 10-14 days after surgery […] Consider continuing for 28 to 35 days post-op […] Special circumstances: Elective hip surgery […] Ambulation before the second post-surgical day […] Management: Thromboprophylaxis in Critical Illness and Major Trauma […] Start within 12-24 hours of major Trauma or when otherwise hemodynamically stable without active bleeding […] Low Molecular Weight Heparin (LMWH or Enoxaparin or Lovenox) […] Standard dose: 40 mg every 24 hours […] Very high VTE Risk: 30 mg SC every 12 hours
  • #57 Deep Vein Thrombosis Prevention
    https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm
    Mechanical Thromboprophylaxis […] Indications […] Alternative to Pharmacologic Thromboprophylaxis in patients who are bleeding or high risk of bleeding […] Preferred Anticoagulants for Thromboprophylaxis in hospitalized patients […] Low Molecular Weight Heparin (LMWH, Lovenox) […] Overall preferred Anticoagulant for Thromboprophylaxis […] Other Anticoagulants for Thromboprophylaxis in hospitalized patients (esp. post-surgical) […] Precautions […] Indications […] Contraindications […] Preferred in renal Impairment […] Management: Venous Thromboembolism Prevention in Cancer […] Medications used for prophylaxis in cancer (typically up to 6 months) […] References […] DVT Prophylaxis Guidelines.
  • #58 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
    https://emedicine.medscape.com/article/1268573-overview
    Mechanical methods have been shown to be a useful adjunct to anticoagulation therapy in reducing the incidence of DVT. Modalities include passive devices, such as knee- or thigh-high graduated compression (elastic) stockings; active (external pneumatic compress or intermittent pneumatic compression [IPC]) devices; or venous foot pumps (VFP). A 2012 systematic review of randomized, controlled trials found that knee- and thigh-high GCS do not significantly differ in their effectiveness in reducing the incidence of DVT in hospitalized patients. In a study of the efficacy of IPC in multiple postoperative patient groups versus no use of prophylaxis, Urbankova et al reported that the incidence of DVT was reduced by 60%. However, the use of mechanical means of prophylaxis alone is not effective in moderate or high-risk cases. IPC devices are designed to decrease venous stasis, improve blood flow velocity, and increase the level of circulating fibrinolysins. These devices have the advantage of requiring no monitoring, with no increase in bleeding. Generally, they are well tolerated. Various forms of IPC devices are available, and they can be applied to the foot, calf, or thigh. Although all three types of mechanical compression reduce the incidence of DVT to less than that found when prophylaxis is absent, these modalities are generally less effective at producing such reductions than pharmacologic methods are. Shorter hospital stays make the use of mechanical methods alone ineffective in preventing DVT in the critical weeks after joint replacement. No mechanical prophylaxis method has been shown to reduce the risk of PE or death. The use of IPC devices is therefore recommended primarily as an adjunct to anticoagulant-based prophylaxis or in patients who are at high risk of bleeding.
  • #59 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods
    https://emedicine.medscape.com/article/1268573-overview
    Many pharmacologic agents are currently available to prevent thrombosis. Agents that retard or inhibit the process belong under the general heading of anticoagulants. Agents that prevent the growth or formation of thrombi are properly termed antithrombotics and include anticoagulants and antiplatelet drugs, whereas thrombolytic drugs lyse existing thrombi. In a systematic review and meta-analysis (61 studies) evaluating the efficacy of 11 anticoagulants for preventing VTE after total hip arthroplasty (THA) or total knee arthroplasty (TKA), Huang et al found apixaban, edoxaban, fondaparinux, rivaroxaban, and darexaban to be the most efficacious agents. […] In separate studies, Rosendaal, Kearon, and Bulger et al analyzed the relative contribution of individual risk factors to the development of DVT. When more than one risk factor is present, the risk is cumulative; however, no good model suggests how the individual risk factors interact. Nonetheless, several attempts have been made to quantify the risk factors associated with VTE. The use of a checklist to stratify patients and assign them to categories of relative propensity for DVT development is helpful in deciding on an appropriate treatment regimen. A list can be constructed by using the ACCP risk categories. These figures include a list of the pertinent factors, which are arbitrarily assigned a risk level between 1 and 5. Risk factors are grouped according to severity and are added to produce an overall risk factor score, which corresponds to a low through a very high potential for DVT development.
  • #60 Best Practices Preventing Deep Vein Thrombosis and Pulmonary Embolism
    https://www.outcomes-umassmed.org/dvt/best_practice/
    Giving prophylaxis to those who are at risk should be a routine practice in your hospital. […] The approach to DVT prevention is similar to preventing postoperative wound infections. […] The keys to preventing DVT are in knowing who is at risk, when to apply the preventive measure, and applying the appropriate measure. […] Prophylaxis is preferred to treatment, as venous thromboembolism can be hard to diagnose and, in the case of PE, there is often no warning that the patient is at risk. […] In high-risk groups of patients, it is more cost effective to protect against DVT and PE than to treat these conditions when they occur. […] Patients at risk of venous thromboembolism can be identified, and there are methods of prophylaxis available to reduce the incidence of complications in many of these patients.
  • #61 Best Practices Preventing Deep Vein Thrombosis and Pulmonary Embolism
    https://www.outcomes-umassmed.org/dvt/best_practice/
    Effective prophylactic regimens differ according to the type of patient at high risk. […] Prophylactic therapy should be tailored to the patients disease and degree of risk. […] DVT and PE in these patients can be significantly reduced by prophylactic regimens, which should be used more extensively. […] Regimens recommended for prevention of DVT and PE include low-dose heparin, adjusted-dose heparin, dextran and warfarin. […] Low-dose warfarin, external pneumatic compression and gradient elastic stockings, alone or in combination with heparin or heparin/DHE are also effective in decreasing DVT, which the panel considers to be an indicator of their effectiveness on PE. […] The application of prophylactic measures is much more effective for preventing death and morbidity from pulmonary embolism than is treatment of the established event.
  • #62 Best Practices Preventing Deep Vein Thrombosis and Pulmonary Embolism
    https://www.outcomes-umassmed.org/dvt/best_practice/
    Primary prophylaxis is likely to be more effective, less expensive, and is the prophylaxis of choice in most clinical circumstances. […] Patients in high-risk groups should receive, in addition, pharmacological prophylaxis. […] The choice of prophylaxis has widened since 1986 when the consensus statements on methods of prophylaxis in at-risk patients were first issued. […] Many of the prophylactic measures that can be taken are simple, and newer approaches to prophylaxis are proving that the risks of postoperative thrombosis can be reduced considerably with little risk to the patient.
  • #63 Prevention of Deep Vein Thrombosis & Pulmonary Embolism – Blood Clots
    https://www.stoptheclot.org/learn_more/prevention_of_thrombosis/
    Ask your doctor about need for blood thinners or compression stockings to prevent clots, whenever you go to the hospital. […] Stay active. […] Exercise regularly; walking is fine. […] Avoid long periods of staying still. […] Get up and move around at least every hour whenever you travel on a plane, train, or bus, particularly if the trip is longer than 4 hours. […] Talk to your doctor about your risk of clotting whenever you take hormones, whether for birth control or replacement therapy, or during and right after any pregnancy. […] Follow any self-care measures to keep heart failure, diabetes, or any other health issues as stable as possible. […] The longer you’re seated without movement, the greater the risk. The good news? Awareness can save lives. Moving your legs regularly, staying hydrated, and knowing the signs and symptoms of blood clots can make all the difference. Learn more about how to prevent blood clots at the link in bio.